Article
Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response
19 Apr 2018
Abstract excerpt
Ewing sarcoma is an aggressive pediatric cancer that is driven by a fusion oncogene, EWS-FLI1. While the transcriptional targets of EWS-FLI1 have been widely studied, the systemic impact of EWS-FLI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
